Deb Hart | Head of Investor Relations |
Carl Hull | Chairman of the Board and Interim CEO |
Kevin Herde | Chief Financial Officer |
Becky Buzzeo | Chief Commercial Officer |
Trey Martin | President Biologics Safety Testing |
Drew Burch | EVP, Nucleic Acid Production |
Conor McNamara | RBC Capital Markets |
Catherine Schulte | Robert W. Baird |
Matthew Sykes | Goldman Sachs |
Daniel Leonard | Credit Suisse |
Daniel Arias | Stifel |
John Sourbeer | UBS |
Tejas Savant | Morgan Stanley |
Good afternoon. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Maravai LifeSciences First Quarter 2023 Earnings Conference Call. [Operator Instructions]
Deb Hart, Head of Investor Relations, you may begin your conference.